Bath & Body Works, Inc. $BBWI Shares Bought by Quantinno Capital Management LP

Quantinno Capital Management LP grew its position in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 537.3% during the first quarter, HoldingsChannel reports. The firm owned 965,771 shares of the company’s stock after buying an additional 814,228 shares during the period. Quantinno Capital Management LP’s holdings in Bath & Body Works were worth $18,031,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in BBWI. Chase Investment Counsel Corp purchased a new stake in Bath & Body Works during the 4th quarter worth $1,606,000. Intech Investment Management LLC boosted its position in Bath & Body Works by 462.6% in the 4th quarter. Intech Investment Management LLC now owns 108,766 shares of the company’s stock valued at $2,184,000 after buying an additional 89,432 shares during the last quarter. Cibc World Market Inc. acquired a new stake in shares of Bath & Body Works during the fourth quarter valued at about $2,053,000. WINTON GROUP Ltd acquired a new stake in shares of Bath & Body Works during the fourth quarter valued at about $3,175,000. Finally, Vaughan Nelson Investment Management L.P. increased its position in shares of Bath & Body Works by 33.8% during the first quarter. Vaughan Nelson Investment Management L.P. now owns 2,852,040 shares of the company’s stock worth $53,248,000 after acquiring an additional 719,795 shares during the last quarter. 95.14% of the stock is owned by institutional investors and hedge funds.

Bath & Body Works Stock Performance

Shares of Bath & Body Works stock opened at $20.13 on Monday. The firm has a market cap of $4.06 billion, a PE ratio of 5.66, a price-to-earnings-growth ratio of 1.99 and a beta of 1.38. Bath & Body Works, Inc. has a 1 year low of $14.27 and a 1 year high of $32.32. The firm’s 50-day simple moving average is $20.15 and its 200-day simple moving average is $20.36.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings data on Wednesday, May 27th. The company reported $0.32 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.03. Bath & Body Works had a negative return on equity of 45.34% and a net margin of 10.03%.The firm had revenue of $1.38 billion during the quarter, compared to analyst estimates of $1.36 billion. During the same period in the previous year, the company earned $0.49 earnings per share. Bath & Body Works’s quarterly revenue was down 3.2% on a year-over-year basis. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. On average, equities analysts predict that Bath & Body Works, Inc. will post 2.63 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, June 19th. Stockholders of record on Friday, June 5th were issued a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 4.0%. The ex-dividend date was Friday, June 5th. Bath & Body Works’s payout ratio is 22.47%.

Analyst Ratings Changes

Several research firms recently commented on BBWI. Telsey Advisory Group cut their price target on Bath & Body Works from $25.00 to $22.00 and set a “market perform” rating on the stock in a research note on Thursday, May 28th. UBS Group dropped their price objective on Bath & Body Works from $22.00 to $19.00 and set a “neutral” rating on the stock in a report on Wednesday, May 20th. Jefferies Financial Group upped their target price on Bath & Body Works from $22.00 to $23.00 and gave the company a “hold” rating in a research report on Tuesday, July 28th. Barclays reduced their target price on Bath & Body Works from $25.00 to $23.00 and set an “equal weight” rating for the company in a research note on Thursday, May 28th. Finally, Weiss Ratings raised shares of Bath & Body Works from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, July 9th. Three investment analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $21.93.

About Bath & Body Works

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.